Theravance Biopharma, Inc. Reports Second Quarter 2022 Financial Results and Provides Business Update
Go back to Theravance Biopharma, Inc. Reports Second Quarter 2022 Financial Results and Provides Business Update| REPROS THERAPEUTICS (NASDAQ: RPRX) | Delayed: 60.30 -0.29 (0.48%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $60.59 | 52 Week High | $3.48 | |||
| Open | $60.60 | 52 Week Low | $0.80 | |||
| Day High | $60.80 | P/E | N/A | |||
| Day Low | $59.31 | EPS | $-1.54 | |||
| Volume | 1,406,865 | |||||
| (NASDAQ: TBPH) | Delayed: 17.06 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $17.06 | 52 Week High | $38.92 | |||
| Open | $17.07 | 52 Week Low | $12.87 | |||
| Day High | $17.08 | P/E | N/A | |||
| Day Low | $17.06 | EPS | $0.00 | |||
| Volume | 30,189 | |||||
